BackAscendis Pharma A/S Overview

Ascendis Pharma A/S Current Cash

Latest current cash for ASND: $570M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$573.42M
↑ 10.71% YoYΔ $55.49M vs prior year quarter

Peer average

Loading

Ascendis Pharma A/S Current Cash History

Loading

Ascendis Pharma A/S vs. peers: Current Cash Comparison

Loading

Ascendis Pharma A/S Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Ascendis Pharma A/S (ASND) FAQ

Ascendis Pharma A/S (ASND) currently reports a current cash of $570M as of March 2026. That compares with $520M in the prior-year period — up 10.7% year over year. Use the charts on this page to explore Ascendis Pharma A/S's current cash history and peer comparisons.

Ascendis Pharma A/S's current cash increased from $520M to $570M — a 10.7% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ascendis Pharma A/S reported $570M in current cash as of March 2026. That compares with $520M in the prior-year period — up 10.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $570M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ascendis Pharma A/S, and consider following ASND for alerts when major investors trade the stock.

Ascendis Pharma A/S is classified in the Healthcare sector. On current cash, it currently shows $570M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ASND with unrelated industries.